Research article · 15 Apr 2026
Conference abstractPublished 26 Jun 2014
Proteomic analysis of the effects of farnesyltransferase inhibitor on vascular disease in experimental model of chronic renal failure
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
T he mevalonate pathway plays an important role in both dyslipidemia and inflammation because of its implication in cholesterol synthesis, and in the activation of several key cellular proteins such as the GTPases and Ras. An increase of plasma mevalonate concentration has been documented in chronic kidney disease (CKD) patients. The importance of mevalonate products in CKD has been demonstrated indirectly by the beneficial effects of statins. The specific inhibition of protein prenylation, by a farnesyltransferase inhibitor (FTI), offers the possibility to test the hypothesis of a direct role of isoprenoids in CKD-associated vascular lesions. In our studies we have explored the role of the specific inhibition of protein prenylation on the vascular calcification process and atherosclerosis in a well-defined apolipoprotein E null (apoE-/-) mouse model with CKD. Proteomic analysis and profiling by MALDI-TOF-MS to identify the relevant peptides and then nano LC-MSMS to sequence were used. It was observed that an inhibitory action of FTI on systemic inflammation and oxidative stress in CKD mice which was suggested by the observed changes in apolipoprotein AIV, α globin, and fetuin A. Moreover, by using immunohistochemistry, we observed reduced vascular nitrotyrosine expression as a marker for oxidative stress. In conclusion, it will be shown in the presentation that the FTI is effective in slowing the accelerated progression of atherosclerosis and vascular calcification in apoE-/-mouse model with CKD. The talk will also show that the inhibition of protein prenylation leads to a decrease in oxidative stress, inflammation, atherogenesis, and vascular calcification, via both systemic and direct local effects on the vessel wall
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Igor G Nikolov”
